<< Medical Facilities announces financial results for the third quarter of 2009 | Bradmer Pharmaceuticals reports financial results for the third quarter of 2009 >>
Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Finnish | Ελληνικά | Русский | Svenska | Polski

Financial results for the third quarter announced by A.D.A.M.

Published on November 12, 2009 at 7:34 AM · No Comments

A.D.A.M., Inc. (Nasdaq: ADAM), a leading provider of health information and benefit technology solutions, today announced its financial results for the third quarter ended September 30, 2009.

Highlights:

  • License revenues for the third quarter of 2009 were $6.7 million, up 7% over third quarter of 2008
  • Adjusted operating income margin for the third quarter of 2009 was 23% as compared to 18% in the third quarter of 2008
  • Net income for the third quarter of 2009 was $1.3 million, or $0.13 per share on a fully diluted basis, up 88% from the third quarter of 2008
  • Adjusted EBITDA was $2.4 million for the third quarter of 2009, up 24% from third quarter 2008

“We are pleased with the performance of our licensing business for the third quarter,” said Kevin Noland, A.D.A.M.’s president and chief executive officer. “Health content licensing performed extremely well and we experienced another good quarter of bookings related to Benergy and our online enrollment products. As many of our new enrollment clients will begin their implementations in the fourth quarter, this should give us a nice start to 2010. As a result of our continued investments in infrastructure to support our expected growth, we are now processing approximately 25% more employee enrollments than last year, with the fastest response times we have ever recorded during the first week of the November peak season.”

Financial Results:

Third Quarter Highlights

License revenues for the third quarter ended September 30, 2009 were $6.7 million, compared to $6.3 million in the third quarter of 2008, an increase of 7%. The increase from the prior year reflects an increase in health content license revenue of 20%, the result of new client contracts, strong retention rates and improved results from distribution partners.

Total revenues for the third quarter ended September 30, 2009 were $7.0 million, compared to $7.1 million in the third quarter of 2008. The change reflects the lower level of product sales related to the Company’s education business and professional services provided in 2009, which was partially offset by the increase in license revenues noted previously.

Adjusted operating income was $1.6 million, or 23% of revenues, compared to $1.3 million, or 18% of revenues for the third quarter of 2009 and 2008, respectively. Adjusted operating income improved due to the Company’s cost cutting measures that reduced cost of revenues by 25% and operating expenses by 10%.

Cash flow, as measured by Adjusted EBITDA was $2.4 million, or 34% of revenues, for the third quarter ended September 30, 2009, as compared to $1.9 million or 27% of revenues for the same period a year ago.

Net income for the third quarter ended September 30, 2009 was $1.3 million or $0.13 per share on a fully diluted basis as compared to net income of $688,000 or $0.06 per share on a fully diluted basis for the third quarter of 2008.

Non-GAAP net income, which excludes charges for stock-based compensation and amortization of purchased intangibles, was $1.6 million, an increase of 38% from the same period a year ago.

September Year-to-Date Highlights

License revenues for the nine-month period ended September 30, 2009, were $19.4 million, an increase of 2% from $19.0 million in the same period last year. The increase from prior year reflects an increase in health content license revenues of 10% from new clients and growth from existing accounts.

Adjusted operating income was $4.0 million, compared to $4.1 million, for the nine-months ended September 30, 2009 and 2008, respectively. Both amounts were 19% of revenues for the respective periods.

Cash flow, as measured by Adjusted EBITDA was $5.9 million, or 29% of revenues, for the nine months ended September 30, 2009, as compared to $5.8 million or 27% of revenues for the same period a year ago.

At September 30, 2009, the company had cash and cash equivalents of $3.5 million as compared to $1.4 million at December 31, 2008.

Conference Call

A.D.A.M. will conduct its third quarter earnings conference call today, at 10:00 AM ET. To access the call in the U.S., please dial 866-900-2647 and for international callers, dial 706-758-3362 approximately 10 minutes prior to the start of the conference call. The passcode is 38400536. The conference call will also be broadcast live over the Internet and available for replay for 90 days at http://www.adam.com. In addition, a replay of the call will be available via telephone for one week, beginning two hours after the call. To listen to the telephone replay in the U.S. please dial 800-642-1687 and for international callers, dial 706-645-9291. The passcode is the same as above.

Use of Non-GAAP Measures

To supplement our consolidated financial statements presented in accordance with GAAP, we present investors with certain non-GAAP operational measures, including adjusted operating income, adjusted net income, adjusted earnings per share and adjusted EBITDA, all of which primarily exclude the effects of amortization of intangible assets, stock-based compensation, acquisition related expenses, facility consolidation charges, debt refinancing costs, and a goodwill impairment charge.

Our management considers the total return of an investment we have made in an acquisition (i.e., operating profit generated as compared to the purchase price paid) without taking into consideration any allocations made for accounting purposes. Thus, because the purchase price for an acquisition does not necessarily reflect the accounting value assigned to intangible assets, including customer lists and goodwill, when analyzing the return provided by the acquisition in subsequent periods, our management, for planning and evaluation purposes, excludes the GAAP impact of acquired intangible assets, goodwill impairment charges and other acquisition related expenses to our financial results. We believe that such an approach is useful in understanding the long-term return provided by an acquisition and that our investors benefit from a supplemental non-GAAP financial measure that adjusts for the accounting expense associated with acquired intangible assets.

Similarly, we believe that excluding stock-based compensation expense provides supplemental information and an alternative presentation useful to investors’ understanding of our operating results and trends, especially when comparing those results on a consistent basis to results for previous periods and anticipated results for future periods.

Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.



  Country flag

biuquote
  • Comment
  • Preview
Loading